Ab. Curtis et al., MOTOR-VEHICLE ACCIDENTS IN PATIENTS WITH AN IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, Journal of the American College of Cardiology, 26(1), 1995, pp. 180-184
Objectives. This study was designed to examine driving safety in patie
nts at risk for sudden death after implantation of a cardioverter defi
brillator. Background. Cardioverter-defibrillators are frequently im p
lanted in patients at high risk for sudden death. Despite concern abou
t the safety of driving in these patients, little is known about their
actual motor vehicle accident rates. Methods. Surveys were sent to al
l 742 physicians in the United States involved in cardioverter-defibri
llator implantation and follow-up. Physicians were questioned about nu
mbers of patients followed up, numbers of fatal and nonfatal accidents
, physician recommendations to patients about driving and knowledge of
state driving laws. Results. Surveys were returned by 452 physicians
(61%). A total of 30 motor vehicle accidents related to shocks from im
plantable defibrillators were reported by 25 physicians over a 12-year
period from 1980 to 1992. Of these, nine were Fatal accidents involvi
ng eight patients with a defibrillator and one passenger in a car driv
en by a patient. No bystanders were fatally injured. There were 21 non
fatal accidents involving 15 patients, 3 passengers and 3 bystanders.
The estimated fatality rate for patients with a defibrillator, 7.5/100
,000 patient years, is significantly lower than that for the general p
opulation (18.4/100,000 patient-years, p < 0.05). The estimated injury
rate, 17.6/100,000 patient-years, is also significantly lower than th
at for the general public (2,224/100,000 patient-years, p < 0.05). Onl
y 10.5% (30 of 286) of all defibrillator discharges during driving res
ulted in accidents. Regarding physician recommendations, most physicia
ns (58.1%) ask their patients to wait a mean (+/-SD) of 7.3 +/- 3.4 mo
nths after implantation or a shock before driving again. Conclusions.
The motor vehicle accident rate caused by discharge from an implantabl
e cardioverter defibrillator is low. Although restricting driving for
a short period of time after implantation may be appropriate, excessiv
e restrictions or a total ban on driving appears to be unwarranted.